Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia

The safety, pharmacokinetics and biological effect of plerixafor in children as part of a conditioning regimen for chemo-sensitization in allogeneic hematopoietic stem cell transplantation (HSCT) have not been studied. This is a phase I study of plerixafor designed to evaluate its tolerability at do...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Srinivasan, Ashok, Panetta, John C., Cross, Shane, Pillai, Asha, Triplett, Brandon M., Shook, Dave R., Dallas, Mari H., Hartford, Christine, Sunkara, Anusha, Kang, Guolian, Jacobsen, Jeffrey, Choi, John, Leung, Wing
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631218/
https://ncbi.nlm.nih.gov/pubmed/24769325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.04.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars